Fabio Malavasi - Publications, H-index & Citations

Fabio Malavasi

laboratory of immunogenetics

81H指数

515论文数

2.1W被引数

收录论文 131

发表时间

Modulating CD38 enzymatic activity during antibody-based immunotherapy in multiple myeloma: a basic science perspective 在多发性骨髓瘤中调节抗体为基础的免疫疗法期间的CD38酶活性：基础科学视角

Frontiers in Immunology

IF5.9

2026-04-29

OAAI

AL Alberto L. Horenstein; KA Kristine A. Frerichs; AC Angelo C. Faini; NW Niels W. C. J. van de Donk; FM Fabio Malavasi

Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects

FRONTIERS IN IMMUNOLOGY

IF5.9

2025-02-12

OAAI

Horenstein, Alberto L.; Faini, Angelo C.; Morandi, Fabio; Ortolan, Erika; Storti, Paola; Giuliani, Nicola; Richardson, Paul G.; Malavasi, Fabio

Immune-regulatory properties carried by human amnion epithelial cells: Focus on the role of HLA-G and adenosinergic ectoenzymes 人羊膜上皮细胞的免疫调节特性: 关注hla-g和腺苷能胞外酶的作用

HUMAN IMMUNOLOGY

IF2.2

2023-08-01

PREAI

Morandi, F.; Airoldi, I.; Faini, A.; Horenstein, A.; Malavasi, F.; Matysiak, N.; Kopaczka, K.; Marimpietri, D.; Gramignoli, R.

Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-12-21

OAAI

Agarbati, S.; Benfaremo, D.; Viola, N.; Paolini, C.; Svegliati Baroni, S.; Funaro, A.; Moroncini, G.; Malavasi, F.; Gabrielli, A.

Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes

ANNALS OF HEMATOLOGY

IF2.4

2022-08-09

OAAI

Leleu, Xavier; Martin, Thomas; Weisel, Katja; Schjesvold, Fredrik; Iida, Shinsuke; Malavasi, Fabio; Manier, Salomon; Min, Chang-Ki; Ocio, Enrique M.; Pawlyn, Charlotte; Perrot, Aurore; Quach, Hang; Richter, Joshua; Spicka, Ivan; Yong, Kwee; Richardson, Paul G.

CD38 IN THE AGE OF COVID-19: AMEDICAL PERSPECTIVE 新型冠状病毒肺炎时代的CD38: 医学视角

PHYSIOLOGICAL REVIEWS

IF28.7

2021-10-01

OAAI

Horenstein, Alberto L.; Faini, Angelo C.; Malavasi, Fabio

Blending oxytocin and dopamine with everyday creativity

SCIENTIFIC REPORTS

IF3.9

2021-08-10

OAAI

Chong, Anne; Tolomeo, Serenella; Xiong, Yue; Angeles, Dario; Cheung, Mike; Becker, Benjamin; Lai, Poh San; Lei, Zhen; Malavasi, Fabio; Tang, Qianzi; Chew, Soo Hong; Ebstein, Richard P.

The Key Role of NAD+ in Anti-Tumor Immune Response: An Update

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-04-15

OAAI

Morandi, Fabio; Horenstein, Alberto Leonardo; Malavasi, Fabio

Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis

CELLS

IF5.2

2021-03-04

OAAI

Palladini, Giovanni; Milani, Paolo; Malavasi, Fabio; Merlini, Giampaolo

Comparison of CD38 antibodies in vitro and ex vivo mechanisms of action in multiple myeloma

HAEMATOLOGICA

IF7.9

2021-01-14

OAAI

Kinder, Michelle; Bahlis, Nizar J.; Malavasi, Fabio; de Goeij, Bart; Babich, Alexander; Sendecki, Jocelyn; Rusbuldt, Joshua; Bellew, Kevin; Kane, Colleen; van de Donk, Niels W. C. J.

Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model

CELLS

IF5.2

2020-12-11

OAAI

Zannetti, Beatrice Anna; Faini, Angelo Corso; Massari, Evita; Geuna, Massimo; Maffini, Enrico; Poletti, Giovanni; Cerchione, Claudio; Martinelli, Giovanni; Malavasi, Fabio; Lanza, Francesco

The Circular Life of Human CD38: From Basic Science to Clinics and Back 人类CD38的循环生命: 从基础科学到临床

MOLECULES

IF4.6

2020-10-21

OAAI

Horenstein, Alberto L.; Faini, Angelo C.; Morandi, Fabio; Bracci, Cristiano; Lanza, Francesco; Giuliani, Nicola; Paulus, Aneel; Malavasi, Fabio

CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells

FRONTIERS IN IMMUNOLOGY

IF5.9

2020-10-02

OAAI

Fortunato, Orazio; Belisario, Dimas Carolina; Compagno, Mara; Giovinazzo, Francesca; Bracci, Cristiano; Pastorino, Ugo; Horenstein, Alberto; Malavasi, Fabio; Ferracini, Riccardo; Scala, Stefania; Sozzi, Gabriella; Roz, Luca; Roato, Ilaria; Bertolini, Giulia

Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses

BLOOD ADVANCES

IF7.1

2020-05-18

OAAI

Manna, Alak; Kellett, Timothy; Aulakh, Sonikpreet; Lewis-Tuffin, Laura J.; Dutta, Navnita; Knutson, Keith; Chini, Eduardo; Pinilla-Ibarz, Javier; Lamanna, Nicole; Manochakian, Rami; Malavasi, Fabio; Sher, Taimur; Chanan-Khan, Asher A.; Ailawadhi, Sikander; Paulus, Aneel

The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections CD38/NAD/SIRTUIN1/EZH2轴可减轻细胞毒性CD8 T细胞功能并识别易感染的SLE患者

CELL REPORTS

IF6.9

2020-01-01

110

OAAI

Katsuyama, Eri; Suarez-Fueyo, Abel; Bradley, Sean J.; Mizui, Masayuki; Marin, Ana V.; Mulki, Lama; Krishfield, Suzanne; Malavasi, Fabio; Yoon, Joon; Sui, Shannan J. Ho; Kyttaris, Vasileios C.; Tsokos, George C.

CD38 is functionally dependent on the TCR/CD3 complex in human T cells

FASEB JOURNAL

IF4.2

2019-12-25

112

OAAI

Morra, M; Zubiaur, M; Terhorst, C; Sancho, J; Malavasi, F

Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma

FRONTIERS IN IMMUNOLOGY

IF5.9

2019-09-04

OAAI

Lam, Jian Hang; Ng, Harry Ho Man; Lim, Chun Jye; Sim, Xin Ni; Malavasi, Fabio; Li, Huihua; Loh, Josh Jie Hua; Sabai, Khin; Kim, Joo-Kyung; Ong, Clara Chong Hui; Loh, Tracy; Leow, Wei Qiang; Choo, Su Pin; Toh, Han Chong; Lee, Ser Yee; Chan, Chung Yip; Chew, Valerie; Lim, Tong Seng; Yeong, Joe; Lim, Tony Kiat Hon

Molecular Pathways in Support of Allogenic Human Amnion Epithelial Cell Transplantation for Liver Disease Without Immunosuppression

TRANSPLANTATION

IF5

2019-09-01

PREAI

Gramignoli, Roberto; Morandi, Fabio; Horenstein, Alberto; Srinivasan, Raghuramanan; Malavasi, Fabio; Strom, Stephen

Editorial: Immunotherapy in Multiple Myeloma

FRONTIERS IN IMMUNOLOGY

IF5.9

2019-08-14

OAAI

Giuliani, Nicola; Malavasi, Fabio